Michelle Dipp Phones & Addresses
-
New York, NY
-
Boston, MA
-
Cambridge, MA
-
El Paso, TX
-
Houston, TX
Business Records
Name / Title
Company / Classification
Phones & Addresses
Manager
LONGWOOD FUND GP, LLC
800 Boylston St, Boston, MA 02199
Manager
LONGWOOD FUND MANAGEMENT, LLC
800 Boylston St, Boston, MA 02199
Governing
EL PASO MANAGEMENT GROUP, LLC
PO Box 55, El Paso, TX 79940
8 Museum Way APT 1104, Cambridge, MA 02141
8 Museum Way APT 1104, Cambridge, MA 02141
Ceo, Chief Executive Officer, President
OvaScience
Hospital & Health Care · Medical Laboratory · Nonclassifiable Establishments
Hospital & Health Care · Medical Laboratory · Nonclassifiable Establishments
215 1 St, Cambridge, MA 02142
800 Boylston St, Boston, MA 02199
800 Boylston St, Boston, MA 02199
Vice-President
Band Gap Engineering
Engineering Services
Engineering Services
6 Gill St, Woburn, MA 01801
Chairman
City On A Hill Charter School
Elementary/Secondary School Business Consulting Services · Elementary & Secondary Schools
Elementary/Secondary School Business Consulting Services · Elementary & Secondary Schools
58 Circuit St, Boston, MA 02119
18 Hulbert St, Boston, MA 02119
(617) 445-1515, (617) 445-9153
18 Hulbert St, Boston, MA 02119
(617) 445-1515, (617) 445-9153
VP Corporate Development
SIRTRIS PHARMACEUTICALS, INC
Mfg Pharmaceutical Preparations
Mfg Pharmaceutical Preparations
200 Technology Dr, Cambridge, MA 02139
1250 S Collegeville Rd, Collegeville, PA 19426
200 Technology Sq, Cambridge, MA 02139
(617) 252-6920
1250 S Collegeville Rd, Collegeville, PA 19426
200 Technology Sq, Cambridge, MA 02139
(617) 252-6920
President
HEALTHY LIFESPAN INSTITUTE, INC
Noncommercial Research Organization
Noncommercial Research Organization
2 International Pl, Boston, MA 02110
2 International Pl, Boston, MA 02110
31 Milk St, Boston, MA 02109
(617) 646-4530
2 International Pl, Boston, MA 02110
31 Milk St, Boston, MA 02109
(617) 646-4530
Publications
Us Patents
Treatment Of Eye Disorders With Sirtuin Modulators
View pageUS Patent:
20070014833, Jan 18, 2007
Filed:
Oct 28, 2005
Appl. No.:
11/374278
Inventors:
Michael Milburn - Cary NC, US
Christoph Westphal - Brookline MA, US
Michelle Dipp - Cambridge MA, US
Christoph Westphal - Brookline MA, US
Michelle Dipp - Cambridge MA, US
Assignee:
Sirtris Pharmaceuticals, Inc. - Cambridge MA
International Classification:
A61K 31/7052
A61K 31/724
A61K 31/05
A61K 31/724
A61K 31/05
US Classification:
424427000, 514058000, 514043000, 514733000, 977906000
Abstract:
Sirtuin modulators, particularly sirtuin activators, are useful in treating vision impairment. In general, the sirtuin modulators inhibit the progression of vision impairment resulting from various eye disorders. The invention also includes pharmaceutically acceptable formulations of sirtuin modulators, particular ophthalmically acceptable formulations.
Methods And Related Compositions For Treating Or Preventing Obesity, Insulin Resistance Disorders, And Mitochondrial-Associated Disorders
View pageUS Patent:
20070149466, Jun 28, 2007
Filed:
Mar 16, 2006
Appl. No.:
11/374295
Inventors:
Michael Milburn - Cary NC, US
Jill Milne - Brookline MA, US
Johan Auwerx - Hindisheim, FR
Carmen Argmann - Strasbourg, FR
Marie Lagouge - Strasbourg, FR
Michelle Dipp - Cambridge MA, US
Jill Milne - Brookline MA, US
Johan Auwerx - Hindisheim, FR
Carmen Argmann - Strasbourg, FR
Marie Lagouge - Strasbourg, FR
Michelle Dipp - Cambridge MA, US
International Classification:
A61K 31/7056
A61K 31/05
A61K 31/05
US Classification:
514043000, 514733000
Abstract:
Provided herein are methods and compositions for treating or preventing metabolic disorders, such as obesity and diabetes. Methods may comprise modulating the activity or level of a sirtuin, such as SIRT1 or Sir2. Exemplary methods comprise contacting a cell with a sirtuin activating compound, such as a flavone, stilbene, flavanone, isoflavone, catechin, chalcone, tannin or anthocyanidin, or an inhibitory compound, such as nicotinamide.
Novel Compositions For Preventing And Treating Neurodegenerative And Blood Coagulation Disorders
View pageUS Patent:
20060276393, Dec 7, 2006
Filed:
Jan 13, 2006
Appl. No.:
11/332056
Inventors:
Michael Milburn - Cary NC, US
Jill Milne - Brookline MA, US
Christoph Westphal - Brookline MA, US
Karl Normington - Acton MA, US
Jennifer Fujii - Lexington MA, US
Michelle Dipp - Cambridge MA, US
Peter Elliott - Marlborough MA, US
Jill Milne - Brookline MA, US
Christoph Westphal - Brookline MA, US
Karl Normington - Acton MA, US
Jennifer Fujii - Lexington MA, US
Michelle Dipp - Cambridge MA, US
Peter Elliott - Marlborough MA, US
Assignee:
Sirtris Pharmaceuticals, Inc. - Cambridge MA
International Classification:
A61K 38/17
A61K 31/7048
A61K 31/353
A61K 31/05
A61K 31/7048
A61K 31/353
A61K 31/05
US Classification:
514012000, 514027000, 514456000, 514733000
Abstract:
Provided herein are methods and compositions for treating or preventing neurodegenerative disorders or blood coagulation disorders. Methods may comprise modulating the activity or level of a sirtuin, such as SIRT1 or Sir2. Exemplary methods comprise contacting a cell with a sirtuin activating compound, such as a flavone, stilbene, flavanone, isoflavone, catechin, chalcone, tannin or anthocyanidin; or an inhibitory compound, such as nicotinamide.
Wikipedia References
Michelle Dipp
Work:
Position:
Vice president
Education:
Area of science:
Leadership
Academic degree:Doctor of Philosophy
Skills & Activities:
Skill:
Venture capital
Master status:Subordinate